HK Stock MarketDetailed Quotes

SHING CHI HLDGS (01741)

Watchlist
  • 0.305
  • 0.0000.00%
Market Closed May 21 15:30 CST
244.00MMarket Cap-20.33P/E (TTM)

SHING CHI HLDGS (01741) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q6)Mar 31, 2025
(FY)Sep 30, 2024
(Q6)Mar 31, 2024
(FY)Sep 30, 2023
(Q6)Mar 31, 2023
(FY)Sep 30, 2022
(Q6)Mar 31, 2022
(FY)Sep 30, 2021
(Q6)Mar 31, 2021
Cash flow from operating activities
Earning before tax
-19.53%-11.97M
----
-295.42%-10.02M
----
98.18%-2.53M
----
-459.66%-139.09M
----
-327.49%-24.85M
----
Profit adjustment
Interest (income) - adjustment
58.72%-90K
----
14.84%-218K
----
-924.00%-256K
----
85.96%-25K
----
93.83%-178K
----
Interest expense - adjustment
-88.80%168K
----
-19.35%1.5M
----
528.38%1.86M
----
-14.45%296K
----
13.07%346K
----
Dividend (income)- adjustment
----
----
----
----
2.24%-349K
----
-91.94%-357K
----
-1,760.00%-186K
----
Attributable subsidiary (profit) loss
----
----
163.29%208K
----
--79K
----
----
----
----
----
Impairment and provisions:
-41.71%1.53M
----
49.94%2.62M
----
-47.46%1.75M
----
-30.84%3.32M
----
3,596.15%4.81M
----
-Impairment of property, plant and equipment (reversal)
-98.33%9K
----
--538K
----
----
----
----
----
----
----
-Other impairments and provisions
-27.07%1.52M
----
19.13%2.08M
----
-47.46%1.75M
----
-30.84%3.32M
----
3,596.15%4.81M
----
Revaluation surplus:
----
----
----
----
-99.51%3K
----
57.44%614K
----
207.09%390K
----
-Other fair value changes
----
----
----
----
-99.51%3K
----
57.44%614K
----
207.09%390K
----
Asset sale loss (gain):
----
----
-1,467.01%-39.71M
----
---2.53M
----
----
----
1,450.00%27K
----
-Loss (gain) from sale of subsidiary company
----
----
-1,285.14%-39.7M
----
---2.87M
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
----
-103.01%-10K
----
--332K
----
----
----
--27K
----
Depreciation and amortization:
-96.94%281K
----
6.28%9.19M
----
0.36%8.64M
----
10.77%8.61M
----
58.54%7.78M
----
Special items
----
----
-1,333.33%-43K
----
---3K
----
----
----
---45K
----
Operating profit before the change of operating capital
72.34%-10.09M
----
-647.97%-36.47M
----
105.26%6.66M
----
-962.41%-126.63M
----
-188.33%-11.92M
----
Change of operating capital
Inventory (increase) decrease
----
----
104.16%31K
----
53.61%-746K
----
-130.04%-1.61M
----
-353.26%-699K
----
Accounts receivable (increase)decrease
-91.92%5.76M
----
234.23%71.22M
----
-169.78%-53.06M
----
190.60%76.04M
----
-938.96%-83.93M
----
Accounts payable increase (decrease)
67.40%-3.5M
----
-170.15%-10.74M
----
125.04%15.31M
----
-152.89%-61.16M
----
469.59%115.64M
----
Financial assets at fair value (increase)decrease
----
----
----
----
--4.15M
----
----
----
----
----
Special items for working capital changes
-98.40%273K
----
205.30%17.06M
----
-124.77%-16.2M
----
245.89%65.38M
----
-2,360.96%-44.81M
----
Cash  from business operations
-118.39%-7.56M
-124.42%-2.45M
193.64%41.09M
125.18%10.04M
8.53%-43.89M
-46.98%-39.88M
-86.53%-47.98M
-89.03%-27.13M
6.08%-25.72M
56.23%-14.35M
Other taxs
----
----
-22.37%-93K
-164.29%-37K
-155.07%-76K
-16.67%-14K
-54.75%138K
99.54%-12K
108.45%305K
27.92%-2.6M
Dividend received - operating
----
----
----
----
-2.24%349K
16.67%7K
91.94%357K
-25.00%6K
1,760.00%186K
-11.11%8K
Special items of business
----
----
----
----
--4.15M
----
----
----
----
----
Net cash from operations
-118.44%-7.56M
-124.51%-2.45M
203.89%41M
125.08%10M
16.89%-39.47M
-46.97%-39.89M
-88.20%-47.49M
-60.13%-27.14M
18.57%-25.23M
53.43%-16.95M
Cash flow from investment activities
Interest received - investment
-58.72%90K
-22.33%80K
-14.84%218K
-25.90%103K
924.00%256K
6,850.00%139K
-85.96%25K
-98.88%2K
-93.83%178K
-90.23%178K
Loan receivable (increase) decrease
----
----
----
---324K
----
----
----
----
----
----
Sale of fixed assets
----
----
--10K
--10K
----
----
536.54%331K
----
--52K
----
Purchase of fixed assets
98.98%-9K
98.89%-9K
57.68%-884K
-60.67%-813K
-58.86%-2.09M
-61.66%-506K
47.53%-1.32M
60.48%-313K
-716.29%-2.51M
-357.80%-792K
Sale of subsidiaries
----
----
-27,460.00%-1.38M
----
---5K
----
----
----
----
----
Acquisition of subsidiaries
----
----
----
--81K
----
----
---2.83M
----
----
----
Recovery of cash from investments
----
----
----
----
----
----
----
----
--15M
--15M
Cash on investment
----
----
----
----
---583K
----
----
----
66.72%-4.99M
----
Net cash from investment operations
103.98%81K
107.53%71K
15.99%-2.03M
-156.95%-943K
36.14%-2.42M
-18.01%-367K
-149.03%-3.79M
-102.16%-311K
-81.40%7.73M
-74.15%14.39M
Net cash before financing
-119.19%-7.48M
-126.28%-2.38M
193.03%38.97M
122.51%9.06M
18.31%-41.89M
-46.64%-40.25M
-193.02%-51.28M
-971.81%-27.45M
-265.16%-17.5M
-113.30%-2.56M
Cash flow from financing activities
New borrowing
----
----
----
-7.90%91.55M
1,237.12%254.8M
370.09%99.4M
--19.06M
--21.15M
----
----
Refund
----
----
81.62%-39.57M
-97.07%-108.53M
-1,029.48%-215.23M
-160.44%-55.07M
---19.06M
---21.15M
----
----
Interest paid - financing
88.80%-168K
92.15%-70K
19.35%-1.5M
-72.87%-892K
-528.38%-1.86M
-111.48%-516K
14.45%-296K
41.06%-244K
-13.07%-346K
-225.98%-414K
Absorb investment income
----
----
----
----
--1.87M
----
----
----
----
----
Net cash from financing operations
94.31%-2.72M
93.24%-1.42M
-237.61%-47.84M
-150.52%-20.96M
827.93%34.77M
2,401.22%41.49M
40.49%-4.78M
69.73%-1.8M
-84.93%-8.03M
-188.47%-5.96M
Effect of rate
----
----
95.78%-19K
45.74%137K
46.36%-450K
-60.17%94K
-31.09%-839K
266.20%236K
-329.53%-640K
-1,192.31%-142K
Net Cash
-14.97%-10.2M
68.08%-3.8M
-24.62%-8.87M
-1,060.45%-11.9M
87.30%-7.12M
104.24%1.24M
-119.60%-56.05M
-243.41%-29.25M
-508.07%-25.53M
-149.55%-8.52M
Begining period cash
-21.45%32.56M
-21.45%32.56M
-15.44%41.45M
-15.44%41.45M
-53.72%49.02M
-53.72%49.02M
-19.81%105.91M
-19.81%105.91M
4.85%132.08M
4.85%132.08M
Cash at the end
-31.33%22.36M
-3.12%28.76M
-21.45%32.56M
-41.04%29.69M
-15.44%41.45M
-34.52%50.35M
-53.72%49.02M
-37.69%76.9M
-19.81%105.91M
-13.80%123.42M
Cash balance analysis
Bank deposits
----
----
----
----
----
-5.90%6.67M
----
343.13%7.09M
----
-98.62%1.6M
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Sep 30, 2025(Q6)Mar 31, 2025(FY)Sep 30, 2024(Q6)Mar 31, 2024(FY)Sep 30, 2023(Q6)Mar 31, 2023(FY)Sep 30, 2022(Q6)Mar 31, 2022(FY)Sep 30, 2021(Q6)Mar 31, 2021
Cash flow from operating activities
Earning before tax -19.53%-11.97M-----295.42%-10.02M----98.18%-2.53M-----459.66%-139.09M-----327.49%-24.85M----
Profit adjustment
Interest (income) - adjustment 58.72%-90K----14.84%-218K-----924.00%-256K----85.96%-25K----93.83%-178K----
Interest expense - adjustment -88.80%168K-----19.35%1.5M----528.38%1.86M-----14.45%296K----13.07%346K----
Dividend (income)- adjustment ----------------2.24%-349K-----91.94%-357K-----1,760.00%-186K----
Attributable subsidiary (profit) loss --------163.29%208K------79K--------------------
Impairment and provisions: -41.71%1.53M----49.94%2.62M-----47.46%1.75M-----30.84%3.32M----3,596.15%4.81M----
-Impairment of property, plant and equipment (reversal) -98.33%9K------538K----------------------------
-Other impairments and provisions -27.07%1.52M----19.13%2.08M-----47.46%1.75M-----30.84%3.32M----3,596.15%4.81M----
Revaluation surplus: -----------------99.51%3K----57.44%614K----207.09%390K----
-Other fair value changes -----------------99.51%3K----57.44%614K----207.09%390K----
Asset sale loss (gain): ---------1,467.01%-39.71M-------2.53M------------1,450.00%27K----
-Loss (gain) from sale of subsidiary company ---------1,285.14%-39.7M-------2.87M--------------------
-Loss (gain) on sale of property, machinery and equipment ---------103.01%-10K------332K--------------27K----
Depreciation and amortization: -96.94%281K----6.28%9.19M----0.36%8.64M----10.77%8.61M----58.54%7.78M----
Special items ---------1,333.33%-43K-------3K---------------45K----
Operating profit before the change of operating capital 72.34%-10.09M-----647.97%-36.47M----105.26%6.66M-----962.41%-126.63M-----188.33%-11.92M----
Change of operating capital
Inventory (increase) decrease --------104.16%31K----53.61%-746K-----130.04%-1.61M-----353.26%-699K----
Accounts receivable (increase)decrease -91.92%5.76M----234.23%71.22M-----169.78%-53.06M----190.60%76.04M-----938.96%-83.93M----
Accounts payable increase (decrease) 67.40%-3.5M-----170.15%-10.74M----125.04%15.31M-----152.89%-61.16M----469.59%115.64M----
Financial assets at fair value (increase)decrease ------------------4.15M--------------------
Special items for working capital changes -98.40%273K----205.30%17.06M-----124.77%-16.2M----245.89%65.38M-----2,360.96%-44.81M----
Cash  from business operations -118.39%-7.56M-124.42%-2.45M193.64%41.09M125.18%10.04M8.53%-43.89M-46.98%-39.88M-86.53%-47.98M-89.03%-27.13M6.08%-25.72M56.23%-14.35M
Other taxs ---------22.37%-93K-164.29%-37K-155.07%-76K-16.67%-14K-54.75%138K99.54%-12K108.45%305K27.92%-2.6M
Dividend received - operating -----------------2.24%349K16.67%7K91.94%357K-25.00%6K1,760.00%186K-11.11%8K
Special items of business ------------------4.15M--------------------
Net cash from operations -118.44%-7.56M-124.51%-2.45M203.89%41M125.08%10M16.89%-39.47M-46.97%-39.89M-88.20%-47.49M-60.13%-27.14M18.57%-25.23M53.43%-16.95M
Cash flow from investment activities
Interest received - investment -58.72%90K-22.33%80K-14.84%218K-25.90%103K924.00%256K6,850.00%139K-85.96%25K-98.88%2K-93.83%178K-90.23%178K
Loan receivable (increase) decrease ---------------324K------------------------
Sale of fixed assets ----------10K--10K--------536.54%331K------52K----
Purchase of fixed assets 98.98%-9K98.89%-9K57.68%-884K-60.67%-813K-58.86%-2.09M-61.66%-506K47.53%-1.32M60.48%-313K-716.29%-2.51M-357.80%-792K
Sale of subsidiaries ---------27,460.00%-1.38M-------5K--------------------
Acquisition of subsidiaries --------------81K-----------2.83M------------
Recovery of cash from investments ----------------------------------15M--15M
Cash on investment -------------------583K------------66.72%-4.99M----
Net cash from investment operations 103.98%81K107.53%71K15.99%-2.03M-156.95%-943K36.14%-2.42M-18.01%-367K-149.03%-3.79M-102.16%-311K-81.40%7.73M-74.15%14.39M
Net cash before financing -119.19%-7.48M-126.28%-2.38M193.03%38.97M122.51%9.06M18.31%-41.89M-46.64%-40.25M-193.02%-51.28M-971.81%-27.45M-265.16%-17.5M-113.30%-2.56M
Cash flow from financing activities
New borrowing -------------7.90%91.55M1,237.12%254.8M370.09%99.4M--19.06M--21.15M--------
Refund --------81.62%-39.57M-97.07%-108.53M-1,029.48%-215.23M-160.44%-55.07M---19.06M---21.15M--------
Interest paid - financing 88.80%-168K92.15%-70K19.35%-1.5M-72.87%-892K-528.38%-1.86M-111.48%-516K14.45%-296K41.06%-244K-13.07%-346K-225.98%-414K
Absorb investment income ------------------1.87M--------------------
Net cash from financing operations 94.31%-2.72M93.24%-1.42M-237.61%-47.84M-150.52%-20.96M827.93%34.77M2,401.22%41.49M40.49%-4.78M69.73%-1.8M-84.93%-8.03M-188.47%-5.96M
Effect of rate --------95.78%-19K45.74%137K46.36%-450K-60.17%94K-31.09%-839K266.20%236K-329.53%-640K-1,192.31%-142K
Net Cash -14.97%-10.2M68.08%-3.8M-24.62%-8.87M-1,060.45%-11.9M87.30%-7.12M104.24%1.24M-119.60%-56.05M-243.41%-29.25M-508.07%-25.53M-149.55%-8.52M
Begining period cash -21.45%32.56M-21.45%32.56M-15.44%41.45M-15.44%41.45M-53.72%49.02M-53.72%49.02M-19.81%105.91M-19.81%105.91M4.85%132.08M4.85%132.08M
Cash at the end -31.33%22.36M-3.12%28.76M-21.45%32.56M-41.04%29.69M-15.44%41.45M-34.52%50.35M-53.72%49.02M-37.69%76.9M-19.81%105.91M-13.80%123.42M
Cash balance analysis
Bank deposits ---------------------5.90%6.67M----343.13%7.09M-----98.62%1.6M
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --------Unqualified Opinion------Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More